pindolol has been researched along with Heart Diseases in 10 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to clarify whether chronic administration of metoprolol had any influence on cardiac beta-adrenergic receptors (BAR) in doxorubicin (DOX)-induced cardiac damage." | 1.28 | Chronic effects of metoprolol on myocardial beta-adrenergic receptors in doxorubicin-induced cardiac damage in rats. ( Fujita, N; Hiroe, M; Horie, T; Hosoda, S; Ohta, Y, 1991) |
| "Hypertrophic cardiomyopathy is characterized by a nondilated, hypertrophied left ventricle in the absence of any overt cause." | 1.28 | Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. ( Epstein, SE; McIntosh, C; Porterfield, J; Sax, FL; Snyder, SH; Wagner, JA; Weisfeldt, ML; Weisman, HF, 1989) |
| "Carazolol was active at considerably lower doses than pindolol (about 25 times less) and propranolol (about 100 times later)." | 1.26 | Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats. ( Bartsch, W; Dietmann, K; Kohler, M; Sponer, G, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moses, JW | 1 |
| Borer, JS | 1 |
| Bartsch, W | 1 |
| Sponer, G | 1 |
| Dietmann, K | 1 |
| Kohler, M | 1 |
| Kenedi, I | 1 |
| Fujita, N | 1 |
| Hiroe, M | 1 |
| Ohta, Y | 1 |
| Horie, T | 1 |
| Hosoda, S | 1 |
| Wagner, JA | 1 |
| Sax, FL | 1 |
| Weisman, HF | 1 |
| Porterfield, J | 1 |
| McIntosh, C | 1 |
| Weisfeldt, ML | 1 |
| Snyder, SH | 1 |
| Epstein, SE | 1 |
| Schalekamp, MA | 1 |
| Man in't Veld, AJ | 1 |
| Lutz, E | 1 |
| Petersen, P | 1 |
| Bartelt, KM | 1 |
| Martin, KL | 1 |
| Kaltenbach, M | 1 |
| Passa, P | 1 |
| Masquet, C | 1 |
| Cophignon, J | 1 |
| Gourgon, R | 1 |
| Bouvrain, Y | 1 |
| von Egidy, H | 1 |
| Walter, I | 1 |
| Kusus, T | 1 |
| Wagner, K | 1 |
| Lydtin, H | 1 |
2 reviews available for pindolol and Heart Diseases
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Mono-aminergic receptors and blood pressure.
Topics: Adrenergic beta-Agonists; Blood Pressure; Catechol O-Methyltransferase; Cell Membrane; Clonidine; Do | 1985 |
8 other studies available for pindolol and Heart Diseases
| Article | Year |
|---|---|
Comparative investigation on the cardio-protective action of the beta-blockers carazolol, propranolol and pindolol in rats.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Glycogen; Heart Diseases; Isoproterenol; Mem | 1981 |
[Diagnostic importance of visken -- an adrenergic beta receptor blocking agent].
Topics: Adolescent; Adult; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography; Female; Hear | 1975 |
Chronic effects of metoprolol on myocardial beta-adrenergic receptors in doxorubicin-induced cardiac damage in rats.
Topics: Animals; Body Weight; Doxorubicin; Heart Diseases; Hemodynamics; In Vitro Techniques; Iodocyanopindo | 1991 |
Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Calcium Channels; Cardiomyopathy, Hypertrophic; C | 1989 |
[Blood circulation in forearm in patients suffering from hyperkinetic heart syndrome following beta-stimulation and beta-block].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Blood Circulation; Blood Flow Velocity; For | 1974 |
[The heart in acromegaly. Haemodynamic study].
Topics: Acromegaly; Adult; Aged; Cardiac Output; Diabetes Mellitus; Dye Dilution Technique; Female; Glucagon | 1973 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |
[Effect of a beta receptor blocker on cardiac output--studies in essential hypertension and hyperkinetic heart syndrome with reference to plasma adrenaline and noradrenaline levels].
Topics: Adult; Blood Pressure; Cardiac Output; Epinephrine; Heart Diseases; Heart Rate; Humans; Hypertension | 1973 |